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TGM5 Mutations Impact Epidermal Differentiation
in Acral Peeling Skin Syndrome
Manuela Pigors1, Dimitra Kiritsi1, Cristina Cobzaru1, Agnes Schwieger-Briel1, Jose Sua´rez2, Flavio Faletra3,
Heikki Aho4, Leeni Ma¨kela¨5, Johannes S. Kern1, Leena Bruckner-Tuderman1,6 and Cristina Has1
Acral peeling skin syndrome (APSS) is an autosomal recessive skin disorder characterized by acral blistering and
peeling of the outermost layers of the epidermis. It is caused by mutations in the gene for transglutaminase 5,
TGM5. Here, we report on clinical and molecular findings in 11 patients and extend the TGM5 mutation
database by four, to our knowledge, previously unreported mutations: p.M1T, p.L41P, p.L214CfsX15, and
p.S604IfsX9. The recurrent mutation p.G113C was found in 9 patients, but also in 3 of 100 control individuals in a
heterozygous state, indicating that APSS might be more widespread than hitherto expected. Using quantitative
real-time PCR, immunoblotting, and immunofluorescence analysis, we demonstrate that expression and
distribution of several epidermal differentiation markers and corneodesmosin (CDSN) is altered in APSS
keratinocytes and skin. Although the expression of transglutaminases 1 and 3 was not changed, we found an
upregulation of keratin 1, keratin 10, involucrin, loricrin, and CDSN, probably as compensatory mechanisms for
stabilization of the epidermal barrier. Our results give insights into the consequences of TGM5 mutations on
terminal epidermal differentiation.
Journal of Investigative Dermatology (2012) 132, 2422–2429; doi:10.1038/jid.2012.166; published online 24 May 2012
INTRODUCTION
The cornified layer constitutes the outermost compartment of
the skin, thus forming a robust mechanical barrier against
environmental insults. To accomplish this function, differentiat-
ing keratinocytes build the cornified envelope, which com-
prises a unique structure consisting of highly insoluble proteins,
including loricrin (LOR), filaggrin, and involucrin (IVL), that are
cross-linked by several transglutaminases (Candi et al., 2005).
Genetic defects of the molecules associated with the cornified
envelope lead to disorders of cornification such as ichthyoses
and atopic dermatitis (Proksch et al., 2008; Oji et al., 2010b).
Recently, the underlying genetic causes of particular types of
ichthyoses, the peeling skin syndromes, have been elucidated:
mutations in the corneodesmosin (CDSN) gene primarily
impair the cohesion of corneocytes and lead to generalized
peeling skin disease (Oji et al., 2010a; Bowden, 2011),
whereas transglutaminase 5 (TGase 5), involved in cross-
linking of the cornified envelope proteins, is affected in the
acral peeling skin syndrome (APSS; Cassidy et al., 2005; Oji
et al., 2010a; Pavlovic et al., 2011).
Only little is known on the molecular disease mechanisms
of APSS (Cassidy et al., 2005; Kiritsi et al., 2010). It is
considered a rare autosomal recessive genodermatosis,
characterized by painless, superficial blistering and peeling
of hands and feet (Shwayder et al., 1997; Cassidy et al.,
2005; Kiritsi et al., 2010). Thus far, three different TGM5
(transglutaminase 5 gene) missense mutations have been
reported, including p.G113C, which is recurrent in the
European population (Cassidy et al., 2005; Kharfi et al.,
2009; Kiritsi et al., 2010; van der Velden et al., 2012).
In this study, we describe 11 patients with APSS and
extend the TGM5 mutation database by four, to our knowl-
edge, previously unreported mutations: p.M1T, p.L41P,
p.L214CfsX15, and p.S604IfsX9. The latter two are the first
TGM5 mutations predicted to lead to premature termination
codons. Furthermore, we show that TGM5 mutations
significantly affect expression of epidermal differentiation
markers and CDSN in vitro and in situ.
RESULTS
Clinical presentation and mutations
This study extends the number of 23 patients with TGM5
mutations, which have been reported previously in the
literature, by 11 (Table 1; Kiritsi et al., 2010). Eight of eleven
patients were children (patients 1–8 in Table 1, age between
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8 months and 12 years) and presented with superficial
blistering and peeling on volar and dorsal aspects of hands
and feet (Figure 1a–c). It is noteworthy that patient 5 reported
to have had erosions on knees after friction, and patient 8 had
large, superficial blisters on the ankles (Figure 1c) and peeling
on the legs, arms, and elbows. The three oldest patients
(patients 9–11 in Table 1), 20, 27, and 33 years of age, only
had peeling and were very mildly affected. In patients 1–4,
7, 8, and 11, epidermolysis bullosa simplex was initially
suspected, and in patients 2, 3, and 7 keratin (KRT) 5 and
14 genes were analyzed and mutations excluded.
We disclosed four previously unreported TGM5 muta-
tions: c.2T4C, p.M1T in exon 1 (in patient 2), c.122T4C,
p.L41P in exon 2 (in patient 5), c.640delC, p.L214CfsX15,
in exon 5 (in patients 3 and 8), and c.1811_1815delinsTCCT
TCA, p.S604IfsX9 in exon 11 (in patient 3; Figure 1b–d,
Table 1). The first mutation affects the start codon and
interferes with the initiation of translation, probably causing
an N-terminal truncated TGase 5. This presumption is
supported by the prediction of additional initiation sites in
the complementary DNA sequence (http://atgpr.dbcls.jp/)
and by the positive TGase 5 signal present in the skin of
the patient (see below). The pathogenic role of the variation
p.L41P is suggested by its absence in 100 control individuals
and by the prediction to be ‘‘possibly damaging’’ (Polyphen,
http://genetics.bwh.harvard.edu/pph/). The deletion c.640delC
causes a frameshift and premature termination of translation,
p.L214CfsX15, in the catalytic core domain. The last mutation,
an insertion/deletion, leads to a frameshift and premature
stop codon formation in the b-barrel 1 domain, p.S604IfsX9,
probably leading to a C-terminal truncation of TGase 5.
However, no material was available to verify whether frame-
shift mutations led to mRNA decay and/or truncated proteins.
The recurrent mutation p.G113C was identified in seven
patients in a homozygous state and in two patients in a
heterozygous state (Table 1). Intriguingly, this mutation was
also detected in a heterozygous state in 3 of 100 control
individuals, together with the single-nucleotide polymorph-
ism p.T109M in all patients and controls.
The parents of patients 3, 5, 6, and 8 were available for
analysis, and were heterozygous carriers of the mutations of
their offspring.
Impact of TGM5 mutations in keratinocytes
As data on TGase 5 functions mainly rely on experi-
ments using recombinant protein (Candi et al., 2001, 2002;
Pietroni et al., 2008), we used APSS as a genetic model to
gain insight into the physiological functions of this enzyme in
Table 1. Clinical features of the patients and mutations
No.
Age at diagnosis,
origin of the
patient Age of onset TGM5 mutations
Site of biopsy,
level of skin
cleavage Clinical features
1 8 Months,
Slovakian
Shortly after
birth
c.[337G4T];[337G4T]
p.[G113C];[G113C]
Lower leg,
no cleavage
Peeling on volar aspects of hands and feet
2 1 Year, origin not
known
7 Months c.[2T4C];[2T4C]
p.[M1T];[M1T]
Sole, intracorneal
blister
Peeling, superficial blisters, and erosions on volar and
dorsal aspects of hands and feet
3 1 Year, Italian 3 Months c.[640delC];
[1811_1815delinsTCCTTCA]
p.[L214CfsX15];[S604IfsX9]
No biopsy
available
Peeling and erythematous patches on hands and feet;
aggravation by heat, friction, perspiration, and exposure
to water
4 2 Years, German Not known c.[337G4T];[337G4T]
p.[G113C];[G113C]
Not known, no
cleavage
Peeling and superficial blisters mainly on volar, but also
on dorsal aspects of hands and feet
5 7 Years, German 6 Weeks c.[122T4C];[337G4T]
p.[L41P];[G113C]
Dorsum of the
foot, no cleavage
Peeling and superficial blisters mainly on dorsal, but
also on volar aspects of hands and feet; peeling on knees
6 7 Years, Spanish 11 Months c.[337G4T];[337G4T]
p.[G113C];[G113C]
Foot, intracorneal
blister
Peeling and superficial blisters on volar and dorsal
aspects of hands and feet; occasionally crusty erosions
on knees and elbows; aggravation upon contact with
water
7 11 Years, German Not known c.[337G4T];[337G4T]
p.[G113C];[G113C]
Foot, intracorneal
blister
Not available
8 12 Years, German 3 Weeks c.[337G4T];[640delC]
p.[G113C];[L214CfsX15]
Not known, no
cleavage
Large, superficial blisters on ankles; mild blistering
and peeling on extremities
9 20 Years,
Hungarian
Since birth c.[337G4T];[337G4T]
p.[G113C];[G113C]
Foot, intracorneal
blister
Mild peeling on volar and dorsal aspects of hands and
feet
10 27 Years, German Not known c.[337G4T];[337G4T]
p.[G113C];[G113C]
Palm, intracorneal
blister
Mild peeling on volar and dorsal aspects of hands and
feet
11 33 Years, German Not known c.[337G4T];[337G4T]
p.[G113C];[G113C]
Lower arm, no
cleavage
Mild peeling on volar and dorsal aspects of feet
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keratinocytes. We analyzed primary keratinocytes derived
from two patients homozygous for the mutation p.G113C
(designated as G113C-keratinocytes). Although cell culture
is not an ideal model to study epidermal differentiation,
treatment of keratinocytes with Ca2þ for 7 days is known
to induce expression of epidermal transglutaminases and
main differentiation proteins (Pillai et al., 1990). These were
analyzed at both mRNA and protein levels.
Interestingly, the TGM5 mRNA levels were markedly
increased (up to 6-fold) in G113C keratinocytes, as compared
with normal keratinocytes (Figure 2a). In contrast, the
expression of the genes for other transglutaminases present
in the upper epidermal layers, transglutaminase 1 (TGM1)
and 3 (TGM3), were comparable to the control. mRNA levels
of TGase 5 substrates (Candi et al., 2005), LOR (4-fold),
and IVL (3-fold), as well as KRT1 (up to 10-fold), were
upregulated, whereas that of KRT5, a marker of basal
keratinocytes, remained unchanged (Figure 2a).
Further, these results were validated at the protein level.
TGase 5 is a highly insoluble protein present in several forms,
including a monomeric form of 84 kDa and an autocatalytic,
cross-linked form of higher molecular mass (Pietroni et al.,
2008). As monomeric TGase 5 is only present to a low extent
in differentiating keratinocytes in vitro (Candi et al., 2002),
only a faint band was detected in all samples. In contrast, the
autocatalytic, inactive form of TGase 5 was enhanced 2-fold
in G113C keratinocytes (Figure 2b), presumably accounting
for the mRNA upregulation. In agreement with the quantita-
tive real-time PCR data, the level of transglutaminase 1
protein (TGase 1) was not changed to compensate for TGase
5 (Figure 2b). More importantly, the expression of IVL was
increased 2-fold and that of CDSN, one of the most crucial
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Figure 1. Clinical presentation of acral peeling skin syndrome and TGM5 mutations. (a–c) Patients presented with peeling and superficial blisters (arrows)
mainly on volar and dorsal aspects of hands and feet. Note large erosions after blisters over the ankles in the 12-year-old patient who was wearing
high-ankle leather shoes during summer. The lower panel shows chromatograms of controls and patients’ partial sequences of exon 3, 2, and 5 of TGM5
indicating the recurrent variation p.G113C, as well as the mutations p.L41P and p.L214CfsX15. (d) Schematic representation of transglutaminase 5 (TGase 5)
and its domains (Grenard et al., 2001). The four, to our knowledge previously unreported, mutations are indicated in red. Both missense mutations, p.M1T
and p.L41P, are located in the b-sandwich domain. The deletion/insertion mutations, p.L214CfsX15 and p.S604Ifsx9, are found in the catalytic core domain
or b-barrel 1 domain of TGase 5, respectively. Previously reported mutations are shown in black. TGase 5 domain structures were designed with the
DOG 2.0 software (Ren et al., 2009).
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cell–cell adhesion molecules in the corneocytes, was
increased up to 6-fold in G113C keratinocytes after 7 days
of Ca2þ stimulation (Figure 2b).
Molecular characterization of APSS skin
Next, we validated the findings in situ by indirect immuno-
fluorescence staining of the skin of patients 2, 5, and 10, all of
them bearing different mutation constellations. All patients
and control samples showed positive signals for TGase 5
confined to the cell membranes, suggesting that the enzy-
matic activity, rather than the expression or localization, is
altered (Figure 3). To investigate this further, we performed an
in situ TGase activity assay. Although this test does not
discriminate among the activities of the epidermal TGases, it
is known that TGase 1 is active at both pH 8.4 and 7.4, and
the optimal pH for TGase 3 and 5 is considered to be B8.4
(Raghunath et al., 1998; Candi et al., 2001). We found
a diminution of TGase activity at pH 8.4 in the skin of all
patients, which was more pronounced in the patient
homozygous for p.M1T. At pH 7.4, TGase activity was
preserved in the skin of all three patients (Figure 3). At both
pH conditions, negative controls showed no fluorescent
signal at the cell periphery.
In agreement with the in vitro data, the signals for CDSN
and LOR were increased in all patients, independent of the
mutations. LOR, in particular, accumulated in the granular
layer and shifted to the upper stratum corneum in the skin of
all three patients, which showed a 2-fold increase of the
intensity of the LOR signal, in contrast to the controls whose
expression was lower and restricted to the granular layer. In
addition, staining for KRT 10 appeared slightly increased in
the patients’ skin. The abnormal signal within the stratum
corneum is most probably due to false-positive antibody
reaction. KRT 5/6 remained unchanged (Figure 4).
In addition, transmission electron microscopy was
performed to unravel more subtle morphological changes
in the APSS skin with the homozygous mutation p.G113C. In
particular, the granular cells contained stellate keratohyalin
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Figure 2. Molecular characterization of acral peeling skin syndrome keratinocytes. (a) Keratinocytes from two patients homozygous for p.G113C
(G113C-keratinocytes) and a control were treated for 7 days with Ca2þ and used for RNA extraction for quantitative real-time PCR (a) and lysates for
immunoblotting (b). Upregulation of the TGM5 transcript was observed in the G113C keratinocytes, whereas levels of TGM1 and TGM3 were comparable to
that of control cells. The differentiation markers loricrin (LOR), involucrin (IVL), and keratin (KRT1) were strongly elevated in the patients’ cells. Keratin 5
(KRT5) remained unchanged. (b) Immunoblotting of control and G113C keratinocytes (G113C-KCs) lysates is shown. Transglutaminase 5 (TGase 5) monomeric
form (lower arrow, 84 kDa) showed similar levels in control and patients’ lysates, whereas the autocatalytic form of TGase 5 (upper arrow) was markedly
increased in the patients’ samples (2-fold). TGase 1 expression remained unchanged in patients’ cells. In contrast, involucrin and corneodesmosin were
increased in the patients as compared with the control. Antibodies to b-actin were used to control loading. The numbers on the left side of each blot
represent molecular weights in kilodaltons.
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Figure 3. Transglutaminase 5 (TGase 5) expression and TGase activity assay in acral peeling skin syndrome skin. Indirect immunofluorescence showed
TGase 5 expression confined to the cell membrane of keratinocytes in all three patients, predominantly in the granular layer of the epidermis. A TGase
activity assay was performed at pH 8.4 and 7.4. The activity at pH 8.4 was reduced at the cell periphery in the upper spinous and granular layers of the skin
of all patients, especially in the patient homozygous for p.M1T. At pH 7.4, TGase activity in patients’s skin was preserved. TGase 2 is active at the level
of the basement membrane zone and dermis. Bars¼50 mm.
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Figure 4. Indirect immunofluorescence staining of control and patients’ skin. In patients’ skin, expression of corneodesmosin, loricrin, and keratin 10
was increased. Particularly, loricrin showed strikingly elevated levels in the patients, and, in contrast to the control skin, it was also present in the cornified layer.
The antibody to loricrin gave a weak signal at the basal layer of the epidermis, which is likely to represent unspecific staining. Keratin 5/6 was not changed.
Skin cleavage occurred within the stratum corneum (asterisk). Bars¼ 50mm.
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granules with abnormal varying electron-dense and less-
dense areas, in addition to homogenously dense areas of
tonofibrils (Figure 5a). The keratinization of the lower horny
cells, as well as the intercellular dense bodies, appeared
unchanged (Figure 5b). Cleavage was observed between the
cornified cells, and the cytoplasm next to the split showed
loosened and disrupted tonofilament bundles (Figure 5c).
Desmosomes were normal and intercellular debris was not
found. The cell membrane and cornified envelope were also
intact (Figure 5d).
DISCUSSION
Here, we describe 11 patients with APSS and four previously
unreported TGM5 mutations, and explore their impact on
epidermal differentiation. Notably, we identified the first
truncating mutations in TGM5, although the majority of the
patients harbored the common mutation p.G113C in either
a heterozygous or homozygous state. For the first time, we
also disclosed p.G113C in patients from Eastern and Southern
Europe, proving it to be a recurrent mutation of possibly
ancestral origin disseminated in Europe (Cassidy et al., 2005;
Kiritsi et al., 2010; van der Velden et al., 2012). But more
importantly, we identified this variant in a heterozygous state
in 3 of 100 control individuals, suggesting that the carrier
frequency and, consequently, APSS may actually be more
widespread than anticipated. As the phenotype is mild, it
could remain undiagnosed or misdiagnosed in most cases.
Patients in this study had mild features, but were referred to
us during episodes of aggravation induced by heat and/or
mechanical trauma.
On the basis of experiments using recombinant enzyme,
TGase 5 has been predicted to be a major contributor to
epidermal differentiation, especially to the formation and
assembly of the cornified envelope (Candi et al., 2002).
In vivo, however, APSS is associated with a limited and mild
clinical picture, which is in contrast to the severe phenotype
of lamellar ichthyosis caused by TGM1 mutations. This
suggests that TGase 1 and 3 are sufficient for a relatively
stable cornified envelope, but environmental insults deter-
mine the disease manifestations.
Although TGase 1 and 3 expression levels are not
increased, common TGase substrates, IVL and LOR, are
upregulated. IVL is an early differentiation marker that
associates, together with envoplakin–periplakin heterotetra-
mers, with the cell membrane of the keratinocytes. The cross-
linking of these proteins at this stage is primarily performed
by TGase 1 in the upper spinous layer (Ishida-Yamamoto
et al., 1996; Steinert and Marekov, 1997; Kalinin et al.,
2001). High levels of IVL in APSS, and the fact that tissue
separation occurs between the granular and cornified layers
or higher, suggest that early processes of cornified envelope
formation are established properly. LOR, on the other hand,
constitutes the main component of the cornified envelope
(Candi et al., 2005) and is expressed during late stages of
cornification to reinforce the already existing scaffold of
cornified envelope precursor proteins (Yoneda and Steinert,
1993; Ishida-Yamamoto et al., 1996; Kalinin et al., 2001).
Before the cross-linking process, LOR is sequestered in
granules, in which it is predicted to complex with profilag-
grin, and possibly also with components of the desmosomes
(Yoneda et al., 1992, 2012; Ishida-Yamamoto et al., 1996).
When TGase 5 activity is missing, incorporation of LOR into
the cornified envelope is impaired and it accumulates in the
granular and cornified layer, which may also explain the
presence of abnormal keratohyalin granules in the granular
cells. Similar to LOR, cross-linking of other components of
the corneocytes will be destabilized by shearing forces and
exposure to water. The ultrastructural findings are very
discreet and similar to those reported previously (Hashimoto
et al., 2000; Cassidy et al., 2005). The level of cleavage in
APSS with TGM5 mutations is unclear (Cassidy et al., 2005;
Kharfi et al., 2009), but in our case it was observed between
the corneocytes.
Further, we hypothesize that owing to the subtle changes
in stability of the cornified envelope in the horny cells
KRTs are upregulated. In this context, the focal disruption of
tonofilament bundles appears very interesting and remains to
be elucidated. Similarly, high levels of CDSN should stabilize
cell–cell contacts as a compensatory mechanism for the
fragile cornified envelope.
In conclusion, our results indicate that TGM5 mutations
induce upregulation of genes for proteins involved in
epidermal differentiation, including KRTs 1 and 10, IVL,
and LOR. As assembly of the cornified cell envelope can be
adequately established in the early stages, presumably by the
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Figure 5. Transmission electron microscope analysis of acral peeling skin
syndrome skin. (a) A detailed electron micrograph of a granular keratinocyte
is shown with stellate keratohyalin granules (g), which were inhomogenously
electron-dense and less electron-dense tonofilaments (t), and nuclear material
(n). Original magnification  5,000. Bar¼ 1,000 nm. (b) The membranes of
the cells in the lower cornified layer were normal, and the intercellular dense
bodies (i) were homogenous. Original magnification  10,000. Bar¼500 nm.
(c) Cleavage (asterisk) was present between the cornified cells, and the
cytoplasm next to the split showed loosened and disrupted tonofilament
bundles (t), but the cell membrane and cornified envelope appeared normal
(v). Original magnification  5,000. Bar¼1,000nm. (d) Desmosomes (d) were
intact between degenerated cells with loosened tonofilaments (t). Original
magnification  10,000. Bar¼ 500nm.
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activity of other TGases, it seems that in patients with APSS
only the terminal formation of the cornified envelope, mainly
consisting of LOR, is disturbed. Consequently, APSS patients
show relatively mild skin fragility at sites of high mechanical
stress. In other body regions that are less burdened, we
assume that other TGases are sufficient to establish a stable
cornified envelope that can resist the mechanical forces of
the environment.
MATERIALS AND METHODS
Patients and clinical samples
The diagnosis was based on clinical assessment and morphological
analysis of skin biopsies. After written informed consent, skin
biopsies and EDTA blood were obtained from the patients, and
whenever possible EDTA blood from their parents for mutation
analysis was also obtained. The project was approved by the ethics
committee of the University of Freiburg and was conducted
according to the Declaration of Helsinki Principles.
Mutation detection
Genomic DNA was extracted from EDTA blood and cultured
keratinocytes using the QiAmp DNA Mini Kit, as well as from
cryosections using the QiAmp DNA FFPE Tissue Kit (both from
Qiagen, Hilden, Germany). Amplification of all 15 TGM5 exons and
exon/intron boundaries was performed as described earlier (Cassidy
et al., 2005). All PCR products were submitted to automated
nucleotide sequencing in an ABI 3130XL genetic analyzer using
Big Dye Terminator Chemistry (Applied Biosystems, Darmstadt,
Germany). DNA sequences were compared with the reference
sequence from NCBI Entrez Nucleotide database (transcript
NM_201631.2 and NG_016124.1) using the Mutation SurveyorTM
DNA variant analysis software (version 2.61 Softgenetics, State
College, PA). Mutations were confirmed by resequencing. Mutation
verification in 100 unrelated control individuals was carried out by
sequencing as well.
Cell culture
Primary keratinocytes from patients’ and control skin were cultured
in serum-free keratinocyte medium supplemented with 25 mgml1
bovine pituitary extract and 0.2 ngml1 recombinant epidermal
growth factor (Invitrogen, Darmstadt, Germany) using standard
methods (Herz et al., 2006). Upon reaching 80–90% confluency,
the cells were treated with 1.2mM CaCl2 for 7 days.
RNA extraction and quantitative real-time PCR
Total RNA was isolated from keratinocytes using the RNeasy Plus
Mini Kit (Qiagen), transcribed into complementary DNA (Fermentas,
St Leon-Rot, Germany), and subjected to quantitative real-time PCR
using the iQTM SYBRw Green Supermix and Biorad CFX96 Real-
Time PCR Detection System (both from Bio-Rad, Munich, Germany).
The data were analyzed using the BioRad CFX Manager Software
(version 1.5). Expression levels were calculated relative to those of
hypoxanthine phosphoribosyltransferase (HPRT1), 18s RNA, and
plakoglobin. Efficiencies were determined for each marker and were
shown to be close to the efficiency of the normalizing marker.
Relative expression was determined as 2DDCT. The control sample
was set to 1, and expression levels in the patient cells were indicated
as fold change compared with the control.
Protein extraction and immunoblot analysis
Keratinocytes were lysed in a buffer containing 25mM Tris-HCl,
pH 8.0, 100mM NaCl, 1mM EDTA, 1mM dithiothreitol, 1% NP-40,
1% Triton X-100, 1mM protease inhibitor cocktail set III (Merck,
Darmstadt, Germany), and 10mM Pefabloc SC (Merck) for 1 hour
with agitation at 4 1C, and clarified by centrifugation at 20,000 g for
20minutes (Pietroni et al., 2008). Immunoblot analysis was
performed as described elsewhere (Has et al., 2009) using primary
antibodies to TGase 5, TGase 1 (both Santa Cruz, Heidelberg,
Germany), IVL (clone SY5; Sigma, Munich, Germany), CDSN (Santa
Cruz), and b-actin (clone AC; Sigma) to control loading. The signals
obtained for IVL and CDSN from western blot analysis were
quantified with the ImageJ gel analysis program (version 1.38,
http://rsbweb.nih.gov/ij/) and normalized to b-actin.
Indirect immunofluorescence staining
Indirect immunofluorescence staining of the patients’ and site-
matched control skin was performed on 5-mm cryosections, which
were air-dried and incubated with primary antibodies at room
temperature overnight. Primary antibodies to the following proteins
were used: TGase 5, CDSN (both Santa Cruz), LOR (Abcam,
Cambridge, UK), KRT 10 (clone LH2; Santa Cruz), and KRT 5/6
(clone D5/16 B4; Dako, Glostrup, Denmark). The secondary
antibodies were Alexa-488 anti-mouse IgG, Alexa-488 anti-goat
IgG, or Alexa-488 anti-rabbit IgG (Invitrogen). Nuclei were stained
with 40,6-diamidino-2-phenylindole (Millipore, Temecula, CA).
Stained sections were observed with an Axiophot fluorescence
microscope (Carl Zeiss, Jena, Germany). Images were captured using
the Zeiss internal software. To quantify LOR expression, the
fluorescence signal of four skin sections of each patient and
matching control was quantified using ImageJ after background
subtraction.
Transglutaminase activity assay
The TGase activity assay was performed as described elsewhere
(Raghunath et al., 1998; Cheng et al., 2010). In brief, 5-mm
cryosections from patients’ and site-matched control skin were
blocked with 1% BSA in 0.1 M Tris/HCl, pH 8.4 or 7.4, for 30minutes
at room temperature, and then incubated with the substrate buffer (at
the respective pH) containing either 5mM CaCl2 or 20mM EDTA (for
the negative control) and biotinylated-X-cadaverine (AnaSpec, San
Jose, CA) for 2 hours at room temperature. The reaction was stopped
by incubating the sections with PBS/10mM EDTA for 5minutes.
The sections were washed two times with PBS and then incubated
with Streptavidin-conjugated Alexa-488 (Invitrogen) for 1 hour,
and washed three times in PBS. Sections were visualized with an
Axiophot fluorescence microscope (Carl Zeiss). Images were
captured using the Zeiss internal software.
Transmission electron microscopy
For electron microscopy, small pieces of tissue were fixed in 3%
glutaraldehyde and postfixed in 1% osmium tetroxide according to
routine procedures. Ultrathin sections were contrasted with uranyl
acetate and lead citrate before being studied in a Jeol JEM 100SX
electron microscope.
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